Becton, Dickinson and Company (BDX)
FlaggedUS listed · Healthcare · Medical Instruments & Supplies
This page tracks Becton, Dickinson and Company (BDX) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews BDX against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Sep 11, 2026Screen strength 0.1The pre-screen score of -0.12/10 is marginally negative, not a genuine STRONG_BUY signal—it sits near the neutral zone and should be read as equivocal. The stock faces multiple headwinds that contradict a bullish thesis: a negative 1Y Sharpe (-0.13) and -2.29% CAGR confirm the stock has underperformed on a risk-adjusted basis; EPS growth of -40.4% YoY signals deteriorating earnings; an extremely elevated P/E of 51.2x with negative earnings growth is a valuation red flag; and price has fallen sharply over the past month (from $192 peak on 8/21 to $175.40 today), breaking below the SMA-50 ($171.91) and now sitting in the $175–179 range with no recovery momentum. The MACD is bearish (histogram -2.546, signal above MACD line) and RSI 40.66 shows no oversold bounce yet. Today's volume (0.24x average) is severely depressed, suggesting capitulation selling without conviction to reverse. A dividend announcement (ex-date 9/9, pay date 9/30) and a recent Wells Fargo conference presentation have not arrested the decline, indicating the market is pricing structural weakness. Wait for either a sustained technical bounce with volume (below SMA-50 support around $168–170) or clearer earnings stabilization before committing.
BDX AI Signal Track Record
Recent scanner signals for Becton, Dickinson and Company. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Sep 11, 2026 | Flagged | 0.1 | $177.85 |
| Sep 11, 2026 | Flagged | 0.1 | $177.85 |
| Sep 11, 2026 | Flagged | 0.1 | $177.85 |
| Sep 11, 2026 | Flagged | 0.1 | $177.85 |
| Sep 11, 2026 | Flagged | 2.3 | $175.26 |
| Sep 10, 2026 | Flagged | 2.6 | $175.83 |
BDX — Frequently Asked Questions
Is Becton, Dickinson and Company (BDX) a buy right now?
As of September 11, 2026, StockTracker AI's screen flags BDX as Flagged, with a ±1.6% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is BDX's RSI?
BDX's 14-day RSI was 40.7 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for BDX?
StockTracker AI generates a probability-weighted 30-day price forecast for BDX — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze BDX?
Each scan screens BDX on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for BDX — free.
Add BDX to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for BDX
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →